Learn how Huntsman Cancer Institute uses cutting‑edge diagnostics and personalized care to treat early‑stage prostate cancer.

The new drug, known as VIR-5500, uses a so-called cloaking device and only activates when it reaches the tumour ...

An imaging test could safely halve the number of people who need a biopsy for suspected prostate cancer following ...

Prostate cancer is one of the leading causes of cancer-related death in men, and some experts project the number of cases to rise over the coming decades. But in a recent Urologic Oncology article, ...

At the 2026 Genitourinary Cancers Symposium in San Francisco, CA, Madan discusses a study investigating short-course (3-month ...

Bayer today announced results from the ongoing global Phase I first-in-human, dose-escalation PAnTHa study (NCT06217822) evaluating the safety, tolerability and preliminary efficacy of ...

There are different ways to manage fatigue during prostate cancer treatment, including exercise, sleep, complementary therapies, and medication.

The ongoing Daro-PET study set out to evaluate the ability of the oral androgen receptor inhibitor darolutamide (Nubeqa) to ...

Former US president Joe Biden has been diagnosed with an “aggressive” form of prostate cancer, which has spread to his bones. But although specialists says such advanced cancer is likely to be ...

"Research on sexual outcomes in prostate cancer survivors has focused on the restoration of erections after treatment," notes a new peer-reviewed article by William Kinnaird and others. "The aim ...